Stella Pharma Corporation (TYO:4888)
Japan flag Japan · Delayed Price · Currency is JPY
431.00
-1.00 (-0.23%)
Nov 18, 2026, 10:00 AM JST

Stella Pharma Statistics

Total Valuation

Stella Pharma has a market cap or net worth of JPY 16.39 billion. The enterprise value is 13.44 billion.

Market Cap16.39B
Enterprise Value 13.44B

Important Dates

The last earnings date was Friday, November 13, 2026.

Earnings Date Nov 13, 2026
Ex-Dividend Date n/a

Share Statistics

Stella Pharma has 38.03 million shares outstanding. The number of shares has increased by 2.39% in one year.

Current Share Class 38.03M
Shares Outstanding 38.03M
Shares Change (YoY) +2.39%
Shares Change (QoQ) +4.03%
Owned by Insiders (%) 3.95%
Owned by Institutions (%) 5.61%
Float 23.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 55.14
PB Ratio 5.01
P/TBV Ratio 5.07
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 45.24
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 15.53, with a Debt / Equity ratio of 0.26.

Current Ratio 15.53
Quick Ratio 11.24
Debt / Equity 0.26
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -67.64

Financial Efficiency

Return on equity (ROE) is -30.50% and return on invested capital (ROIC) is -15.33%.

Return on Equity (ROE) -30.50%
Return on Assets (ROA) -11.34%
Return on Invested Capital (ROIC) -15.33%
Return on Capital Employed (ROCE) -18.31%
Weighted Average Cost of Capital (WACC) 5.72%
Revenue Per Employee 6.34M
Profits Per Employee -20.04M
Employee Count47
Asset Turnover 0.06
Inventory Turnover 0.03

Taxes

In the past 12 months, Stella Pharma has paid 2.00 million in taxes.

Income Tax 2.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +61.80% in the last 52 weeks. The beta is 0.31, so Stella Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.31
52-Week Price Change +61.80%
50-Day Moving Average 401.80
200-Day Moving Average 418.81
Relative Strength Index (RSI) 59.43
Average Volume (20 Days) 758,785

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Stella Pharma had revenue of JPY 298.00 million and -942.00 million in losses. Loss per share was -27.04.

Revenue298.00M
Gross Profit 260.00M
Operating Income -947.00M
Pretax Income -940.00M
Net Income -942.00M
EBITDA -919.00M
EBIT -947.00M
Loss Per Share -27.04
Full Income Statement

Balance Sheet

The company has 3.81 billion in cash and 859.00 million in debt, with a net cash position of 2.95 billion or 77.56 per share.

Cash & Cash Equivalents 3.81B
Total Debt 859.00M
Net Cash 2.95B
Net Cash Per Share 77.56
Equity (Book Value) 3.28B
Book Value Per Share 90.15
Working Capital 5.04B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 28.00M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 87.25%
Operating Margin -317.79%
Pretax Margin -315.44%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Stella Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -2.39%
Shareholder Yield -2.39%
Earnings Yield -6.27%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Stella Pharma has an Altman Z-Score of 3.79 and a Piotroski F-Score of 1.

Altman Z-Score 3.79
Piotroski F-Score 1